drugset / Trial / NCT00920608
A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis Patients
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The main aim of this clinical study is to investigate whether the blood concentration of methotrexate changes when AZD9056 is co- administered together with methotrexate.
Timeline
- Start
- 2009-05
- Primary completion
- —
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD9056 | Small molecule | 400 mg | Oral |
| Subject | Methotrexate | Small molecule | 7.5 mg | Oral |
| Subject | Methotrexate | Small molecule | 20 mg | Oral |